Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
02/2013
02/27/2013EP2561871A1 Diarylhydantoin compounds as androgen receptor antagonists for treatment of cancer
02/27/2013EP2560967A1 Heterocyclic carboxylic acid amides as pdk1 inihibitors
02/27/2013EP2560962A1 Indazole compounds useful as ketohexokinase inhibitors
02/27/2013CN102947293A Triazole-substituted anthranilic acid amides as pesticides
02/27/2013CN102947292A Nitrogen containing heteroaryl compounds
02/27/2013CN102947291A Prodrug of triazolone compound
02/27/2013CN102947289A Arylethynyl derivatives
02/27/2013CN102947274A Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives
02/27/2013CN102942562A Benzimidazole derivative, and preparation method and application thereof
02/27/2013CN102942561A 4-amino quinazoline heterocyclic compound and purpose of 4-amino quinazoline heterocyclic compound
02/27/2013CN102942560A Preparation method of 3-(2-methylindolyl-3-)pyrryl-2,5-dione
02/27/2013CN102942559A Flexible ether oxygen chain pyrimidine derivatives, preparation methods and uses thereof
02/27/2013CN101827828B 1, 2, 4 -triazole derivatives as serotonergic modulators
02/27/2013CN101622229B Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents
02/27/2013CN101511800B Triazolyl phenyl benzenesulfonamides
02/27/2013CN101268058B 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
02/26/2013US8383832 Process for preparing benzimidazole compounds
02/26/2013US8383830 Cyanine compounds and their use in staining biological samples
02/26/2013US8383821 NK-1 and serotonin transporter inhibitors
02/26/2013US8383813 Fused pyrrolocarbazoles
02/26/2013US8383660 Dibenzyl amine compounds and derivatives
02/26/2013US8383654 Heterocyclic antagonists of prostaglandin D2 receptors
02/26/2013US8383633 Aminopyrimidines useful as kinase inhibitors
02/26/2013US8383619 Pharmaceutical compounds
02/26/2013US8383616 Aryl isoxazole compounds with antitumoural activities
02/26/2013CA2534682C Capped pyrazinoylguanidine sodium channel blockers
02/21/2013WO2013025883A1 Heteroaryl sodium channel inhibitors
02/21/2013WO2013025736A2 Dendron reporter molecules
02/21/2013WO2013025560A1 Sweet flavor modifier
02/21/2013WO2013024898A1 Heterocyclic derivative and pharmaceutical drug
02/21/2013WO2013024872A1 Biscarbazole derivative and organic electroluminescence element using same
02/21/2013WO2013024427A1 Novel urea derivatives as tec kinase inhibitors and uses thereof
02/21/2013WO2013024011A1 Indazole compounds, compositions and methods of use
02/21/2013WO2012118715A9 Non-peptidic quenched fluorescent imaging probes
02/21/2013WO2012022120A8 Dihydropyrazole compounds
02/21/2013US20130046095 N-(Heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof
02/21/2013US20130046004 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
02/21/2013US20130045962 Peptide deformylase inhibitors
02/21/2013US20130045955 Novel compounds
02/21/2013US20130045949 Anti-cancer agents
02/21/2013US20130045488 Benzocyanine compounds
02/21/2013US20130043137 Novel compound and use thereof
02/21/2013DE102012107475A1 Benzocyaninverbindungen Benzocyaninverbindungen
02/21/2013DE102010023959B4 Neue Verbindungen als Liganden für Übergangsmetallkomplexe und daraus hergestellte Materialien, sowie Verwendung dazu New compounds as ligands for transition metal complexes and derived materials, and use this
02/21/2013CA2845630A1 Amino quinazolines as kinase inhibitors
02/21/2013CA2844799A1 Heteroaryl sodium channel inhibitors
02/21/2013CA2844794A1 Heterocyclic derivative and pharmaceutical
02/21/2013CA2843499A1 Indazole compounds, compositions and methods of use
02/21/2013CA2841012A1 Sweet flavor modifier
02/20/2013EP2559693A1 Polycyclic compound
02/20/2013EP2559455A1 Heteroaryl derivatives as DGAT1 inhibitors
02/20/2013EP2558461A1 Novel glucokinase activators and methods of using same
02/20/2013EP2558460A1 Triazole-substituted anthranilic acid amides as pesticides
02/20/2013EP2558457A1 Arylethynyl derivatives
02/20/2013EP2558450A1 Triazole compounds as ksp inhibitors
02/20/2013EP2558087A1 AMIDO COMPOUNDS AS RORyt MODULATORS AND USES THEREOF
02/20/2013CN102939288A Process for the preparation of dihydropyrrole derivatives
02/20/2013CN102939284A Agent for treating hcv infection
02/20/2013CN102939283A Indazole compounds useful as ketohexokinase inhibitors
02/20/2013CN102936240A Synthetic method of (R)-5-substituted-3-(N-carbobenzoxy pyrrolidine-2-based carbonyl)-1H-benzpyrole
02/20/2013CN101541789B Hydantoin derivatives used as mmp inhibitors
02/19/2013US8378118 Pyrazole-based thyroid receptor compounds
02/19/2013US8377983 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
02/19/2013US8377981 CBI derivatives subject to reductive activation
02/19/2013US8377942 Isoxazolines derivatives and their use as pesticide
02/19/2013US8377924 Protein kinase C inhibitors and uses thereof
02/19/2013CA2588148C 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof
02/19/2013CA2573371C Pyrimidines as plk inhibitors
02/19/2013CA2562780C Nucleic acid melting analysis with saturation dyes
02/19/2013CA2557054C (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
02/19/2013CA2486187C Kinase inhibitors
02/14/2013WO2013022810A1 Chemical compounds
02/14/2013WO2013021907A1 Organic electric light emitting element, material for said element, and light emitting device, display device, and illumination device employing said element
02/14/2013WO2013021344A1 Imidazole derivatives as antiviral agents
02/14/2013WO2013021337A1 Antiviral compounds with a fused tricyclic ring
02/14/2013WO2013021044A1 1,2,4-triazolyl-substituted keto-enols
02/14/2013WO2013020993A1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
02/14/2013WO2012074840A3 Compositions and methods for in vivo imaging
02/14/2013US20130041153 Derivatives having vinyl group and its use in electroluminescent element
02/14/2013US20130041111 Cross-linking agent for cross-linkable elastomer and application thereof
02/14/2013US20130040977 Pro-Neurogenic Compounds
02/14/2013US20130040964 1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors
02/14/2013US20130040963 Compounds, Compositions and Methods of Using Same for Modulating Uric Acid Levels
02/14/2013US20130040962 P38 MAP Kinase Inhibitors
02/14/2013US20130040949 Type ii raf kinase inhibitors
02/14/2013US20130040944 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
02/14/2013US20130040941 Benzodiazepine compound and pharmaceutical composition
02/14/2013US20130040930 Novel amide derivative and use thereof as medicine
02/14/2013US20130040928 Nitrogen heterocycle derivatives, preparation thereof and application thereof in human therapeutics
02/14/2013US20130040926 Novel compound
02/14/2013US20130040865 Succinimide compound, lubricating oil additive, and lubricating oil composition
02/14/2013US20130037752 Electroluminescent materials comprising fluorene derivatives
02/14/2013CA2855948A1 1,2,4-triazolyl-substituted keto-enols
02/14/2013CA2842123A1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
02/13/2013EP2556071A1 Kinase inhibitors and method of treating cancer with same
02/13/2013EP2556070A1 Synthesis of chiral 2-(1h-indazol-6-yl)-spiro[cyclopropane-1,3'- indolin]-2'-ones
02/13/2013EP2556066A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
02/13/2013EP2556065A1 Pyrazole p38 map kinase inhibitors
02/13/2013EP2555617A1 Novel hypoglycemic compounds
02/13/2013CN102933577A Fungicidal oximes and hydrazones
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 626